FIJYX vs. RAGHX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Virtus Health Sciences Fund (RAGHX).
FIJYX is managed by Fidelity. It was launched on Oct 2, 2018. RAGHX is managed by Allianz. It was launched on Feb 4, 2002.
Performance
FIJYX vs. RAGHX - Performance Comparison
Loading graphics...
FIJYX vs. RAGHX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 2.35% | 40.09% | 0.03% | 11.19% | -7.60% | -2.76% | 32.72% | 26.25% | -11.45% |
RAGHX Virtus Health Sciences Fund | -9.13% | 7.23% | -2.33% | 2.57% | -11.64% | 25.44% | 13.76% | 26.69% | -7.72% |
Returns By Period
In the year-to-date period, FIJYX achieves a 2.35% return, which is significantly higher than RAGHX's -9.13% return.
FIJYX
- 1D
- 5.06%
- 1M
- -0.73%
- YTD
- 2.35%
- 6M
- 15.76%
- 1Y
- 55.98%
- 3Y*
- 18.69%
- 5Y*
- 8.12%
- 10Y*
- —
RAGHX
- 1D
- 2.24%
- 1M
- -8.95%
- YTD
- -9.13%
- 6M
- -0.59%
- 1Y
- 0.22%
- 3Y*
- -0.85%
- 5Y*
- 0.92%
- 10Y*
- 6.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FIJYX vs. RAGHX - Expense Ratio Comparison
FIJYX has a 0.61% expense ratio, which is lower than RAGHX's 1.37% expense ratio.
Return for Risk
FIJYX vs. RAGHX — Risk / Return Rank
FIJYX
RAGHX
FIJYX vs. RAGHX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Virtus Health Sciences Fund (RAGHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FIJYX | RAGHX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.96 | -0.06 | +2.02 |
Sortino ratioReturn per unit of downside risk | 2.56 | 0.05 | +2.51 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.01 | +0.32 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | -0.04 | +3.24 |
Martin ratioReturn relative to average drawdown | 12.85 | -0.12 | +12.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FIJYX | RAGHX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.96 | -0.06 | +2.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | 0.06 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.40 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.48 | -0.05 |
Correlation
The correlation between FIJYX and RAGHX is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FIJYX vs. RAGHX - Dividend Comparison
FIJYX's dividend yield for the trailing twelve months is around 1.41%, while RAGHX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 1.41% | 1.44% | 0.00% | 1.55% | 0.00% | 18.90% | 8.13% | 6.49% | 2.35% | 0.00% | 0.00% | 0.00% |
RAGHX Virtus Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 9.51% | 21.85% | 14.50% | 6.89% | 16.12% | 0.00% | 0.00% | 23.19% |
Drawdowns
FIJYX vs. RAGHX - Drawdown Comparison
The maximum FIJYX drawdown since its inception was -38.53%, roughly equal to the maximum RAGHX drawdown of -40.23%. Use the drawdown chart below to compare losses from any high point for FIJYX and RAGHX.
Loading graphics...
Drawdown Indicators
| FIJYX | RAGHX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.53% | -40.23% | +1.70% |
Max Drawdown (1Y)Largest decline over 1 year | -13.59% | -14.48% | +0.89% |
Max Drawdown (5Y)Largest decline over 5 years | -36.39% | -22.14% | -14.25% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.01% | — |
Current DrawdownCurrent decline from peak | -2.49% | -14.25% | +11.76% |
Average DrawdownAverage peak-to-trough decline | -11.76% | -7.06% | -4.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.69% | 4.79% | -1.10% |
Volatility
FIJYX vs. RAGHX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class Z (FIJYX) has a higher volatility of 9.34% compared to Virtus Health Sciences Fund (RAGHX) at 5.66%. This indicates that FIJYX's price experiences larger fluctuations and is considered to be riskier than RAGHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FIJYX | RAGHX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.34% | 5.66% | +3.68% |
Volatility (6M)Calculated over the trailing 6-month period | 17.01% | 11.56% | +5.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.00% | 19.45% | +6.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.43% | 16.40% | +7.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 17.46% | +7.61% |